bpc-157 fda warning 2024 scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR fda warning letters bpc 157

Sleep apnea The SURMOUNT-OSA trial demonstrated that tirzepatide reduced the severity of obstructive sleep apnea significantly, with some patients achieving complete resolution

Potential therapeutic effects (based on animal and early human data): Enhances tendon, ligament, and muscle repair Promotes angiogenesis (formation of new blood vessels) Reduces inflammation and oxidative stress Protects gut mucosa and may aid in GI disorders (ulcers, leaky gut) May support neurological recovery and joint health Modulates nitric oxide and dopamine/serotonin pathways (possible mood, focus benefits) (Note: Most data are from preclinical studies

Patients who genuinely need clinical intervention are searching alongside those who simply want an energy boost

Stick with veterinary-grade or properly compounded sources

Lee and staff